CN116284017A - 一种利用仿酶高效催化氧化制备酰胺化合物的方法 - Google Patents
一种利用仿酶高效催化氧化制备酰胺化合物的方法 Download PDFInfo
- Publication number
- CN116284017A CN116284017A CN202310306808.1A CN202310306808A CN116284017A CN 116284017 A CN116284017 A CN 116284017A CN 202310306808 A CN202310306808 A CN 202310306808A CN 116284017 A CN116284017 A CN 116284017A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- tertiary amine
- metalloporphyrin
- tfpp
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 amide compound Chemical class 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000007254 oxidation reaction Methods 0.000 title abstract description 27
- 230000003647 oxidation Effects 0.000 title abstract description 23
- 230000003197 catalytic effect Effects 0.000 title abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims abstract description 28
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 21
- 239000001301 oxygen Substances 0.000 claims abstract description 21
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000003054 catalyst Substances 0.000 claims abstract description 19
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 16
- 239000000539 dimer Substances 0.000 claims abstract description 14
- 239000011737 fluorine Substances 0.000 claims abstract description 14
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 14
- 150000004032 porphyrins Chemical group 0.000 claims abstract description 14
- 239000003446 ligand Substances 0.000 claims abstract description 12
- 235000019260 propionic acid Nutrition 0.000 claims abstract description 12
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims abstract description 12
- 239000003999 initiator Substances 0.000 claims abstract description 10
- 239000000758 substrate Substances 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 6
- 150000003935 benzaldehydes Chemical class 0.000 claims abstract description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims abstract description 4
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 78
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 65
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 38
- 239000012153 distilled water Substances 0.000 claims description 31
- 239000002244 precipitate Substances 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 21
- 238000005406 washing Methods 0.000 claims description 21
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 16
- 239000003960 organic solvent Substances 0.000 claims description 16
- 238000001704 evaporation Methods 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- 238000010992 reflux Methods 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 150000003512 tertiary amines Chemical class 0.000 claims description 8
- HBAKJBGOHINNQM-UHFFFAOYSA-N 9-benzylcarbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1CC1=CC=CC=C1 HBAKJBGOHINNQM-UHFFFAOYSA-N 0.000 claims description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- VBBUVIWLZBAEEF-UHFFFAOYSA-N 2,6-dihydroxypyrrolo[3,4-f]isoindole-1,3,5,7-tetrone Chemical compound C1=C2C(=O)N(O)C(=O)C2=CC2=C1C(=O)N(O)C2=O VBBUVIWLZBAEEF-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- NZVZVGPYTICZBZ-UHFFFAOYSA-N 1-benzylpiperidine Chemical compound C=1C=CC=CC=1CN1CCCCC1 NZVZVGPYTICZBZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012670 alkaline solution Substances 0.000 claims description 3
- 150000002505 iron Chemical class 0.000 claims description 3
- CWEGCQIIDCZZED-UHFFFAOYSA-N 1-benzylpyrrolidine Chemical compound C=1C=CC=CC=1CN1CCCC1 CWEGCQIIDCZZED-UHFFFAOYSA-N 0.000 claims description 2
- WCGPCBACLBHDCI-UHFFFAOYSA-N 2,4-difluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C(F)=C1 WCGPCBACLBHDCI-UHFFFAOYSA-N 0.000 claims description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- NLAVHUUABUFSIG-UHFFFAOYSA-N 3,4,5-trifluorobenzaldehyde Chemical compound FC1=CC(C=O)=CC(F)=C1F NLAVHUUABUFSIG-UHFFFAOYSA-N 0.000 claims description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 2
- GVWBJJLCTWNTRU-UHFFFAOYSA-N 4-benzylmorpholine Chemical compound C=1C=CC=CC=1CN1CCOCC1 GVWBJJLCTWNTRU-UHFFFAOYSA-N 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 239000004277 Ferrous carbonate Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 2
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 claims description 2
- 235000019268 ferrous carbonate Nutrition 0.000 claims description 2
- 229960004652 ferrous carbonate Drugs 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229910000015 iron(II) carbonate Inorganic materials 0.000 claims description 2
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000000967 suction filtration Methods 0.000 claims description 2
- GJBRNHKUVLOCEB-UHFFFAOYSA-N tert-butyl benzenecarboperoxoate Chemical compound CC(C)(C)OOC(=O)C1=CC=CC=C1 GJBRNHKUVLOCEB-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 abstract description 8
- 230000001590 oxidative effect Effects 0.000 abstract description 8
- 229910052751 metal Inorganic materials 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 230000004913 activation Effects 0.000 abstract description 2
- 229910052742 iron Inorganic materials 0.000 abstract description 2
- 229910052748 manganese Inorganic materials 0.000 abstract description 2
- 238000006467 substitution reaction Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- BUCKMWPLVBYQCQ-UHFFFAOYSA-N carbazol-9-yl(phenyl)methanone Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C(=O)C1=CC=CC=C1 BUCKMWPLVBYQCQ-UHFFFAOYSA-N 0.000 description 15
- 239000007791 liquid phase Substances 0.000 description 11
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 239000012298 atmosphere Substances 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- 239000011259 mixed solution Substances 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- PIKNVEVCWAAOMJ-UHFFFAOYSA-N 3-fluorobenzaldehyde Chemical compound FC1=CC=CC(C=O)=C1 PIKNVEVCWAAOMJ-UHFFFAOYSA-N 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 229910000510 noble metal Inorganic materials 0.000 description 4
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- ZWDVQMVZZYIAHO-UHFFFAOYSA-N 2-fluorobenzaldehyde Chemical compound FC1=CC=CC=C1C=O ZWDVQMVZZYIAHO-UHFFFAOYSA-N 0.000 description 1
- 238000006237 Beckmann rearrangement reaction Methods 0.000 description 1
- NHOVKACFOMWFAV-UHFFFAOYSA-N FC1=CC=C(C=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N=1)=C2 Chemical compound FC1=CC=C(C=C1)C1=C2NC(=C1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N=1)=C2 NHOVKACFOMWFAV-UHFFFAOYSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 101150053185 P450 gene Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000010930 lactamization Methods 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1805—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing nitrogen
- B01J31/181—Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine
- B01J31/1825—Ligands comprising condensed ring systems, e.g. acridine, carbazole
- B01J31/183—Ligands comprising condensed ring systems, e.g. acridine, carbazole with more than one complexing nitrogen atom, e.g. phenanthroline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2523/00—Constitutive chemical elements of heterogeneous catalysts
- B01J2523/70—Constitutive chemical elements of heterogeneous catalysts of Group VII (VIIB) of the Periodic Table
- B01J2523/72—Manganese
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2523/00—Constitutive chemical elements of heterogeneous catalysts
- B01J2523/80—Constitutive chemical elements of heterogeneous catalysts of Group VIII of the Periodic Table
- B01J2523/84—Metals of the iron group
- B01J2523/842—Iron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
- B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
- B01J2531/025—Ligands with a porphyrin ring system or analogues thereof, e.g. phthalocyanines, corroles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Catalysts (AREA)
Abstract
本发明公开一种利用仿酶高效催化氧化制备酰胺化合物的方法,属于有机合成技术领域。本发明将吡咯与F取代苯甲醛于丙酸中回流,制备氟取代卟啉配体;继续与铁盐配位制备金属卟啉化合物;再于碱液中反应制备金属卟啉二聚体;最后与N‑苄基叔胺底物、助催化剂、引发剂在氧气环境下进行催化氧化反应,制备N‑苯甲酰叔胺产物。本发明通过氟取代提高卟啉环对金属中心的拉电子作用,引入氧桥制备氟取代的卟啉二聚体仿酶催化剂,廉价的Fe、Mn为金属中心可在催化量的氧化剂为引发剂下,提高对氧气分子的活化作用,催化过程无需强氧化剂,以氧气为氧源,室温条件即可实现N‑苄基叔胺转化为N‑苯甲酰叔胺,具有绿色经济的优势。
Description
技术领域
本发明涉及一种利用仿酶高效催化氧化制备酰胺化合物的方法,属于有机合成技术领域。
背景技术
酰胺基团作为化学结构单元中重要的功能性基团之一,存在于许多天然产物中,广泛应用在有机合成、工程塑料原料、洗涤剂和润滑剂等领域。传统上合成酰胺的方法有胺类亲核取代羧酸及其衍生物、腈类的水合作用和贝克曼重排反应。然而这些传统方法通常使用化学计量的有毒有害试剂,产生大量废弃物和副产品,原子经济性差,不符合绿色化学的要求。因此,提供更好的形成酰胺的方法是绿色化学研究领域最重要、最有挑战性的问题之一。在绿色化学的要求下,迫切需要新的方法合成酰胺化合物。
现有研究表明,对胺直接进行α-氧化制酰胺是一种可行的途径,但由于NH2的活性比亚甲基更高,通过α-亚甲基的氧化将胺直接转化为酰胺的情况相对较少。贵金属在胺的直接α氧化展现了重要的用途,固载型催化剂Au:PVP(Gong J,Qi X,Wei D,etal.Org.Bio.Chem,2014,12:7486)、Au/Al2O3(Valeur E,Bradley M,Chem.Soc.Rev,2009,38:606)、Ru(OH)x/Al2O3(Allen C,Chhatwal A,Williams J.Chem.Commun,2012,48:666)已被报道用于胺的α氧化。但上述现有技术涉及较为苛刻的反应条件,并且底物局限在伯胺、仲胺以及环胺的内酰胺化,非贵过渡金属催化氧化叔胺α-氧化的例子较少。
P450单加氧酶和漆酶是两种常见的氧化酶,被报道用于催化多种氧化反应,如杂原子脱烷基、硫氧化、C-N键断裂及氧化偶联等。P450酶的活性中心是Fe-卟啉结构,仿P450酶金属-卟啉催化剂被报道用于甲苯、乙苯及环己烷等饱和C-H键的氧化(Gaba M,Mohan C,Med.Chem.Res.2015,25:173),烯烃氧化及环氧化(Tanabe K,Kogima R,Hatta H,etal.Bioorg.Med.Chem.Lett,2004,14:2633)等反应。
9-苯甲酰咔唑是一种重要的医药中间体,然而从9-苄基咔唑直接构建酰胺键很难,Finkelstein等(Markgraf J H,Sangani P K,Finkelstein M.Synthetic Commun,1997,27:1285)报道了9-苄基咔唑直接氧化为9-苯甲酰咔唑的例子,但是产率仅有26%,而且反应中使用了过量的KMnO4以及其他添加剂,不符合绿色化学的要求。因此,提供一种使用非贵金属催化剂、廉价易得氧化剂、在温和条件下催化氧化叔胺9-苄基咔唑为9-苯甲酰咔唑的方法是十分必要的。
发明内容
本发明针对现有亚甲基氧化制备酰胺化合物方法,存在氧化剂选择性差、剂量高、依赖贵金属催化剂等问题,提供一种利用仿酶催化氧化制备酰胺化合物的方法。
本发明的技术方案:
本发明的目的之一是提供一种仿酶催化剂的制备方法,该方法具体操作过程如下:
S1,将吡咯和氟取代苯甲醛混合在丙酸中回流10h,冷却至室温,过滤,洗涤沉淀,干燥,得到氟取代卟啉配体;
S2,将氟取代卟啉配体、铁盐和有机溶剂混合,升温反应,冷却至室温,加入蒸馏水,过滤,洗涤沉淀后溶于三氯甲烷,使用盐酸洗1次,蒸馏水洗2次,有机相收集干燥后,蒸干得金属卟啉;
S3,将金属卟啉、有机溶剂和碱溶液混合,剧烈搅拌过夜,加入水,蒸干有机溶剂,抽滤得金属卟啉二聚体,即为仿酶催化剂。
进一步限定,S1中氟取代苯甲醛为4-氟苯甲醛、2-氟苯甲醛、2,4-二氟苯甲醛或3,4,5-三氟苯甲醛。
更进一步限定,吡咯和氟取代苯甲醛的物质的量之比为(0.75~1.25):1。
进一步限定,S1得到的氟取代卟啉配体结构为(4-氟苯基)卟啉、(2-氟苯基)卟啉、(2,4-二氟苯基)卟啉或(3,4,5-三氟苯基)卟啉。
进一步限定,S1得到的氟取代卟啉配体的化学结构如下:
进一步限定,S2中铁盐为FeCl2、FeCl2·4H2O、FeBr2、碳酸亚铁、MnCl2、MnCl2·4H2O、FeBr2中的一种或几种混合。
更进一步限定,铁盐与氟取代卟啉配体的物质的量之比为(5~15):1。
进一步限定,S2中有机溶剂为N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲亚砜、N-甲基吡咯烷酮、乙二醇甲醚中的一种或几种混合。
更进一步限定,有机溶剂与氟取代卟啉配体的体积质量比为(50~150)mL:1g。
进一步限定,S2中反应温度为120~170℃,反应时间为1~12h。
进一步限定,S2得到的金属卟啉的活性中心为Fe3+、Mn3+。
更进一步限定,金属卟啉为(4-氟苯基)卟啉氯化铁、(2-氟苯基)卟啉氯化铁、(2,4-二氟苯基)卟啉氯化铁、(3,4,5-三氟苯基)卟啉氯化铁、(4-氟苯基)卟啉氯化锰、(2-氟苯基)卟啉氯化锰、(2,4-二氟苯基)卟啉氯化锰或(3,4,5-三氟苯基)卟啉氯化锰。
更进一步限定,金属卟啉的化学结构如下:
进一步限定,S3中有机溶剂为苯、甲苯、乙二醇二甲醚、氯苯、1,4-二氧六环中的一种或几种混合。
更进一步限定,有机溶剂与金属卟啉的体积质量比为(50~300)mL:1g。
进一步限定,S3中碱溶液中碱为氢氧化钠、氢氧化钾、氢氧化锂、碳酸钠、碳酸氢钠中的一种或几种混合。
更进一步限定,碱溶液为质量分数2~10%的水溶液。
更进一步限定,碱溶液与金属卟啉的体积质量比为(10~100)mL:1g。
进一步限定,S3得到的金属卟啉二聚体为两分子卟啉的金属离子与一分子氧原子形成的二聚体,结构如下:
本发明的目的之二是提供一种应用上述仿酶催化剂催化氧化制备酰胺化合物的方法,该方法为:将叔胺底物加入有机溶剂中,然后加入金属卟啉二聚体、助催化剂和引发剂,在一定压力的氧气环境、室温条件下反应,得N-苯甲酰叔胺产物。
进一步限定,叔胺底物为N-苄基修饰的叔胺化合物,具体为N-苄基哌啶、N-苄基吗啉、N-苄基-四氢吡咯、9-苄基咔唑或N,N-二甲基苄胺。
进一步限定,助催化剂为NHPI、NDHPI、TEMPO中的一种或几种混合。
进一步限定,引发剂为过氧化氢、间氯过氧苯甲酸、过氧苯甲酸叔丁酯、2-碘酰基苯甲酸中的一种或几种混合。
进一步限定,叔胺底物、金属卟啉二聚体、助催化剂和引发剂的物质的量之比为1:(0.001~0.05):(0.01~0.25):(0.01~0.2)。
进一步限定,压力为0.1~10MPa,反应时间为1~48h。
本发明针对现有亚甲基氧化制备酰胺化合物方法,存在氧化剂选择性差、剂量高、依赖贵金属催化剂等问题,利用氟取代的卟啉二聚体为仿酶催化剂,通过催化氧化的方式高效合成酰胺类化合物。与现有技术相比还具有以下有益效果:
(1)本发明通过氟取代提高卟啉环对金属中心的拉电子作用,引入氧桥制备氟取代的卟啉二聚体,以催化量的氧化剂为引发剂提高对氧气分子的活化作用,辅以NHPI等羟胺类自由基引发剂结合Cα-H,活化亚甲基位点为自由基,最后利用活化的氧气分子氧化亚甲基自由基为酰胺结构,产率达到传统氧化剂氧化的2.2倍以上。
(2)本发明利用仿酶高效催化氧化过程无需强氧化剂,以氧气为氧源,廉价的Fe、Mn为金属中心的氟取代卟啉二聚体为催化剂,室温条件即可实现N-苄基叔胺转化为N-苯甲酰叔胺,具有绿色经济的优势。
附图说明
图1为氟取代卟啉配体的化学结构示意图;
图2为金属卟啉的化学结构示意图;
图3为金属卟啉二聚体的化学结构示意图;
图4为9-苄基咔唑的液质检测结果;
图5为实施例8得到的产物9-苯甲酰咔唑的液质结果;
图6为标品9-苯甲酰咔唑的液相检测结果;
图7为实施例8得到的反应液的液相检测结果。
具体实施方式
为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合说明书实施例对本发明的具体实施方式做详细的说明。
在下面的描述中阐述了很多具体细节以便于充分理解本发明,但是本发明还可以采用其他不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似推广,因此本发明不受下面公开的具体实施例的限制。
其次,此处所称的“一个实施例”或“实施例”是指可包含于本发明至少一个实现方式中的特定特征、结构或特性。在本说明书中不同地方出现的“在一个实施例中”并非均指同一个实施例,也不是单独的或选择性的与其他实施例互相排斥的实施例。
实施例1
步骤1:将吡咯(4.50g,0.067mol)和2-氟苯甲醛(8.31g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-1。
步骤2:称取TFPP-1(684mg,1mmol),FeCl2·4H2O(2.544g,12.8mmol),混合于100mLDMF中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-1。
步骤3:剧烈搅拌Fe-TFPP-1(0.2g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-1]2O在水中结晶,用水洗涤粗[Fe-TFPP-1]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Fe-TFPP-1]2O(7.5mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(9.7mg,0.05mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为34.9%。
实施例2:
步骤1:将吡咯(4.50g,0.067mol)和4-氟苯甲醛(8.31g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-2。
步骤2:称取TFPP-2(684mg,1mmol),FeCl2·4H2O(2.544g,12.8mmol),混合于100mLDMF中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-2。
步骤3:剧烈搅拌Fe-TFPP-2(0.2g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-2]2O在水中结晶,用水洗涤粗[Fe-TFPP-2]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Fe-TFPP-2]2O(7.5mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(9.7mg,0.05mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为42.9%。
实施例3:
步骤1:将吡咯(4.50g,0.067mol)和2,4-氟苯甲醛(9.51g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-3。
步骤2:称取TFPP-3(758mg,1mmol),FeCl2·4H2O(2.544g,12.8mmol),混合于100mLDMF中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-3。
步骤3:剧烈搅拌Fe-TFPP-3(0.22g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-3]2O在水中结晶,用水洗涤粗[Fe-TFPP-3]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Fe-TFPP-3]2O(8.2mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(9.7mg,0.05mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为39.7%。
实施例4:
步骤1:将吡咯(4.50g,0.067mol)和3,4,5-氟苯甲醛(10.72g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-4。
步骤2:称取TFPP-4(830mg,1mmol),FeCl2·4H2O(2.544g,12.8mmol),混合于100mLDMF中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-4。
步骤3:剧烈搅拌Fe-TFPP-4(0.24g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-4]2O在水中结晶,用水洗涤粗[Fe-TFPP-4]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Fe-TFPP-4]2O(8.9mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(9.7mg,0.05mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为44.4%。
实施例5:
步骤1:将吡咯(4.50g,0.067mol)和3,4,5-氟苯甲醛(10.72g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-4。
步骤2:称取TFPP-4(830mg,1mmol),MnCl2·4H2O(1.27g,6.4mmol),混合于100mLDMF中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Mn-TFPP-4。
步骤3:剧烈搅拌Mn-TFPP-4(0.24g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Mn-TFPP-4]2O在水中结晶,用水洗涤粗[Mn-TFPP-4]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Mn-TFPP-4]2O(8.9mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(9.7mg,0.05mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为40.5%。
实施例6:
步骤1:将吡咯(4.50g,0.067mol)和3,4,5-氟苯甲醛(10.72g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-4。
步骤2:称取TFPP-4(830mg,1mmol),MnCl2·4H2O(1.27g,6.4mmol),混合于100mLN,N-二甲基乙酰胺中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Mn-TFPP-4。
步骤3:剧烈搅拌Mn-TFPP-4(0.24g,0.26mmol),1,4-二氧六环(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸除1,4-二氧六环,直到[Mn-TFPP-4]2O在水中结晶,用水洗涤粗[Mn-TFPP-4]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NHPI(15mg,0.09mmol),[Mn-TFPP-4]2O(8.9mg,1mol%),溶于氯仿(5mL),加入30%过氧化氢水溶液(6.8mg,0.06mmol),于0.2MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为44.7%。
实施例7:
步骤1:将吡咯(4.50g,0.067mol)和3,4,5-氟苯甲醛(10.72g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-4。
步骤2:称取TFPP-4(830mg,1mmol),MnCl2·4H2O(1.27g,6.4mmol),混合于100mLN,N-二甲基乙酰胺中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Mn-TFPP-4。
步骤3:剧烈搅拌Mn-TFPP-4(0.24g,0.26mmol),1,4-二氧六环(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸除1,4-二氧六环,直到[Mn-TFPP-4]2O在水中结晶,用水洗涤粗[Mn-TFPP-4]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取N-苄基哌啶(129mg,0.5mmol),NDHPI(22mg,0.09mmol),[Mn-TFPP-4]2O(8.9mg,1mol%),溶于二氯甲烷(5mL),加入30%过氧化氢水溶液(6.8mg,0.06mmol),于0.4MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为41.7%。
实施例8:
步骤1:将吡咯(4.50g,0.067mol)和4-氟苯甲醛(8.31g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-2。
步骤2:称取TFPP-2(684mg,1mmol),FeCl2·4H2O(2.544g,12.8mmol),混合于50mLN-甲基吡咯烷酮中,加热回流6h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-2。
步骤3:剧烈搅拌Fe-TFPP-2(0.2g,0.26mmol),甲苯(50mL)和7%LiOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-2]2O在水中结晶,用水洗涤粗[Fe-TFPP-2]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NDHPI(12mg,0.05mmol),[Fe-TFPP-2]2O(7.5mg,1mol%),溶于氯仿(5mL),加入PhCO3tBu(11.6mg,0.06mmol),于0.3MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为45.6%。本实施例制备得到反应液的液质结果和液质结果如图5和7所示,使用的原料9-苄基咔唑液质检测结果如图4所示,标品9-苯甲酰咔唑液相检测结果如图6所示。
对比实施例
0℃条件下于20mL瓶中加入底物(0.5mmol),四乙基溴化铵(116.5mg,0.555mmol),溶于二氯甲烷(10mL),将高锰酸钾(158mg,1mmol)与无水碳酸钠(50mg)分六批加入(每隔10min加入一批,1h加完),室温反应24h,液相定量检测9-苯甲酰咔唑产率为20.1%。
对比可知,本发明仿酶催化氧化体系,以氧气为氧源,相比于传统高锰酸钾直接氧化方法,产率提高至2.2倍以上,体现出更高的催化活性。
实施例9:
步骤1:将吡咯(4.50g,0.067mol)和4-氟苯甲醛(8.31g,0.067mol)混合于丙酸(200mL)中回流10h,反应结束后冷却至室温,加入甲醇与乙酸乙酯的混合溶液(v:v=4:1)洗涤,然后在烘箱中干燥得TFPP-2。
步骤2:称取TFPP-2(684mg,1mmol),FeCl2(1.27g,10mmol),混合于50mL N-甲基吡咯烷酮中,加热回流2h。反应液冷却至室温后,加入150mL蒸馏水,将沉淀过滤,用50mL蒸馏水洗涤沉淀两次,沉淀溶于三氯甲烷,用1M HCl洗1次,蒸馏水洗2次,有机层收集,用无水MgSO4干燥后蒸干得Fe-TFPP-2。
步骤3:剧烈搅拌Fe-TFPP-2(0.2g,0.26mmol),甲苯(50mL)和5%KOH水溶液(10mL)的溶液过夜,向反应器中加入60mL水。然后在真空下蒸发甲苯,直到[Fe-TFPP-2]2O在水中结晶,用水洗涤粗[Fe-TFPP-2]2O并在空气中干燥,甲苯和环己烷重结晶得产品。
步骤4:称取9-苄基咔唑(129mg,0.5mmol),NDHPI(12mg,0.05mmol),[Fe-TFPP-2]2O(15mg,2mol%),溶于氯仿(5mL),加入PhCO3tBu(11.6mg,0.06mmol),于0.16MPa的氧气球环境下室温下反应24h,反应结束后,液相定量检测9-苯甲酰咔唑产率为43.1%。
虽然本发明已以较佳的实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明精神和范围内,都可以做各种的改动与修饰,因此,本发明的保护范围应该以权利要求书所界定的为准。
Claims (10)
1.一种仿酶催化剂的制备方法,其特征在于,包括:
S1,将吡咯和氟取代苯甲醛混合在丙酸中回流10h,冷却至室温,过滤,洗涤沉淀,干燥,得到氟取代卟啉配体;
S2,将氟取代卟啉配体、铁盐和有机溶剂混合,升温反应,冷却至室温,加入蒸馏水,过滤,洗涤沉淀后溶于三氯甲烷,使用盐酸洗1次,蒸馏水洗2次,有机相收集干燥后,蒸干得金属卟啉;
S3,将金属卟啉、有机溶剂和碱溶液混合,剧烈搅拌过夜,加入水,蒸干有机溶剂,抽滤得金属卟啉二聚体,即为仿酶催化剂。
2.根据权利要求1所述的仿酶催化剂的制备方法,其特征在于,S1中氟取代苯甲醛为4-氟苯甲醛、2-氟苯甲醛、2,4-二氟苯甲醛或3,4,5-三氟苯甲醛;吡咯和氟取代苯甲醛的物质的量之比为(0.75~1.25):1。
3.根据权利要求1所述的仿酶催化剂的制备方法,其特征在于,S2中铁盐为FeCl2、FeCl2·4H2O、FeBr2、碳酸亚铁、MnCl2、MnCl2·4H2O、FeBr2中的一种或几种混合;铁盐与氟取代卟啉配体的物质的量之比为(5~15):1。
4.根据权利要求1所述的仿酶催化剂的制备方法,其特征在于,S2中有机溶剂为N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲亚砜、N-甲基吡咯烷酮、乙二醇甲醚中的一种或几种混合;有机溶剂与氟取代卟啉配体的体积质量比为(50~150)mL:1g;S2中反应温度为120~170℃,时间为1~12h。
5.根据权利要求1所述的仿酶催化剂的制备方法,其特征在于,S3中有机溶剂为苯、甲苯、乙二醇二甲醚、氯苯、1,4-二氧六环中的一种或几种混合;有机溶剂与金属卟啉的体积质量比为(50~300)mL:1g。
6.根据权利要求1所述的仿酶催化剂的制备方法,其特征在于,S3中碱溶液中碱为氢氧化钠、氢氧化钾、氢氧化锂、碳酸钠、碳酸氢钠中的一种或几种混合;碱溶液为质量分数2~10%的水溶液,碱溶液与金属卟啉的体积质量比为(10~100)mL:1g。
7.一种酰胺化合物制备方法,其特征在于,利用权利要求1~6任一项所述的方法制备的仿酶催化剂,该方法为:将叔胺底物加入有机溶剂中,然后加入金属卟啉二聚体、助催化剂和引发剂,在一定压力的氧气环境、室温条件下反应,得N-苯甲酰叔胺产物。
8.根据权利要求7所述的酰胺化合物制备方法,其特征在于,叔胺底物为N-苄基修饰的叔胺化合物,具体为N-苄基哌啶、N-苄基吗啉、N-苄基-四氢吡咯、9-苄基咔唑或N,N-二甲基苄胺;助催化剂为NHPI、NDHPI、TEMPO中的一种或几种混合;引发剂为过氧化氢、间氯过氧苯甲酸、过氧苯甲酸叔丁酯、2-碘酰基苯甲酸中的一种或几种混合。
9.根据权利要求7所述的酰胺化合物制备方法,其特征在于,叔胺底物、金属卟啉二聚体、助催化剂和引发剂的物质的量之比为1:(0.001~0.05):(0.01~0.25):(0.01~0.2)。
10.根据权利要求7所述的酰胺化合物制备方法,其特征在于,压力为0.1~10MPa,反应时间为1~48h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310306808.1A CN116284017B (zh) | 2023-03-27 | 2023-03-27 | 一种利用仿酶高效催化氧化制备酰胺化合物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310306808.1A CN116284017B (zh) | 2023-03-27 | 2023-03-27 | 一种利用仿酶高效催化氧化制备酰胺化合物的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116284017A true CN116284017A (zh) | 2023-06-23 |
CN116284017B CN116284017B (zh) | 2024-03-22 |
Family
ID=86835923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310306808.1A Active CN116284017B (zh) | 2023-03-27 | 2023-03-27 | 一种利用仿酶高效催化氧化制备酰胺化合物的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116284017B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723677A (en) * | 1987-01-02 | 1998-03-03 | Sun Company, Inc. (R&M) | Method for hydroperoxide decomposition using novel porphyrins synthesized from dipyrromethanes and aldehydes |
CN1355802A (zh) * | 1999-01-25 | 2002-06-26 | 国家犹太医疗及研究中心 | 取代的卟啉 |
CN105085536A (zh) * | 2015-09-17 | 2015-11-25 | 唐江涛 | 一种四苯基卟吩的制备方法 |
CN105198890A (zh) * | 2015-09-17 | 2015-12-30 | 唐江涛 | 一种四苯基卟吩的生产方法 |
-
2023
- 2023-03-27 CN CN202310306808.1A patent/CN116284017B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723677A (en) * | 1987-01-02 | 1998-03-03 | Sun Company, Inc. (R&M) | Method for hydroperoxide decomposition using novel porphyrins synthesized from dipyrromethanes and aldehydes |
CN1355802A (zh) * | 1999-01-25 | 2002-06-26 | 国家犹太医疗及研究中心 | 取代的卟啉 |
CN105085536A (zh) * | 2015-09-17 | 2015-11-25 | 唐江涛 | 一种四苯基卟吩的制备方法 |
CN105198890A (zh) * | 2015-09-17 | 2015-12-30 | 唐江涛 | 一种四苯基卟吩的生产方法 |
Non-Patent Citations (5)
Title |
---|
BEI WAN, ET AL.: ""Manganese corrole catalyzed selective oxidation of styrene to benzaldehyde: sodium nitrite functions as an oxidant and cocatalyst"", 《ORG. BIOMOL. CHEM》, vol. 20, 31 December 2022 (2022-12-31), pages 7814 * |
CAN-CHENG GUO, ET AL.: ""A new evidence of the high-valent oxo–metal radical cation intermediate and hydrogen radical abstract mechanism in hydrocarbon hydroxylation catalyzed by metalloporphyrins"", 《, JOURNAL OF MOLECULAR CATALYSIS A: CHEMICAL》, vol. 157, 31 December 2000 (2000-12-31), pages 31 - 40 * |
CAN-CHENG GUO: ""Synthesis of ¹-Oxo-bisiron(III)Porphyrin Compounds and Their Catalysis for Cyclohexane Hydroxylation"", 《JOURNAL OF CATALYSIS》, vol. 178, 31 December 1998 (1998-12-31), pages 182 * |
刘强等: ""金属卟啉仿生催化烃类C-H 键氧化活化的基础研 究和应用进展"", 《中国科学》, vol. 42, no. 10, 31 December 2012 (2012-12-31), pages 1399 - 1416 * |
江国防;田渊;郭灿城;: "仿生催化及其在烃类氧化中的应用", 大学化学, no. 02, 28 April 2011 (2011-04-28), pages 1 - 5 * |
Also Published As
Publication number | Publication date |
---|---|
CN116284017B (zh) | 2024-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Selective CC bond scission of ketones via visible-light-mediated cerium catalysis | |
CN113563370B (zh) | 一种壳聚糖负载铜材料催化制备α位有取代基的β-硼基酮的制备方法 | |
Tu et al. | Iron-catalyzed ring-opening of cyclic carboxylic acids enabled by photoinduced ligand-to-metal charge transfer | |
CN104193600A (zh) | 一种以氧化铝为助催化剂空气氧化醇制备醛或酮的方法 | |
WO2018133473A1 (zh) | 一种可见光催化的饱和碳氢键直接氧化方法 | |
Xu et al. | Visible light photocatalytic aerobic oxidative synthesis of imines from alcohols and amines on dye-sensitized TiO2 | |
CN116284017B (zh) | 一种利用仿酶高效催化氧化制备酰胺化合物的方法 | |
CN115093324B (zh) | 一种酯化烷烃的制备方法 | |
CN115433114A (zh) | 一种3-羟基四氢吡咯类化合物的合成方法 | |
CN113318730B (zh) | δ-MnO2催化剂及其制备方法和应用 | |
Luo et al. | Base-mediated carboxylation of C-nucleophiles with CO 2 | |
CN116651512B (zh) | 一种强可见光吸收的Ru-Fe环状光催化剂及其制备方法 | |
CN117050011B (zh) | 一种以醋酸乙烯酯为原料合成2-甲基喹啉的方法 | |
CN115536611B (zh) | 一种制备环氧环己烷的方法 | |
CN112679527B (zh) | 一种合成3-去氨甲酰基-乙酰基-头孢呋辛酸化合物的方法 | |
CN102649082A (zh) | 提高co制草酸酯催化剂活性方法 | |
CN115093346B (zh) | 一种由不同取代环烷酮一步制备腈类化合物的方法 | |
CN110683949B (zh) | 一种制备9,10-菲二羧酸酯类化合物的方法 | |
CN117069654A (zh) | 一种以三聚乙醛为原料合成2-甲基喹啉的方法 | |
Abe et al. | Chlorobenzene-driven palladium-catalysed lactonisation of benzoic acids | |
CN110407763B (zh) | 一种4-(噁唑-2-基)苯甲酸的合成方法 | |
JP2002030059A (ja) | 遷移金属触媒を用いて第3級アミンとシアン化物から酸素酸化によりα−アミノニトリルを製造する方法 | |
CN115536664A (zh) | 一种二氧化碳参与下合成呋喃喹啉类衍生物的方法 | |
CN116925350A (zh) | 一种三嗪共价有机框架ctf-bbs的制备方法及其应用 | |
CN117126101A (zh) | 一种脯氨酸结构的盐酸盐中间体的高效制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |